SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-23-010160
Filing Date
2023-03-31
Accepted
2023-03-31 15:16:16
Documents
69
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2167481
2 ex21-1.htm EX-21.1 6562
3 ex23-1.htm EX-23.1 3565
4 ex31-1.htm EX-31.1 20122
5 ex31-2.htm EX-31.2 20165
6 ex32-1.htm EX-32.1 8390
7 ex32-2.htm EX-32.2 8454
8 form10-k_001.jpg GRAPHIC 5046
9 form10-k_002.jpg GRAPHIC 63165
10 aud_001.jpg GRAPHIC 7861
  Complete submission text file 0001493152-23-010160.txt   10428691

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE atrx-20221231.xsd EX-101.SCH 55439
12 XBRL CALCULATION FILE atrx-20221231_cal.xml EX-101.CAL 39877
13 XBRL DEFINITION FILE atrx-20221231_def.xml EX-101.DEF 280181
14 XBRL LABEL FILE atrx-20221231_lab.xml EX-101.LAB 457906
15 XBRL PRESENTATION FILE atrx-20221231_pre.xml EX-101.PRE 364330
63 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1558688
Mailing Address P.O. BOX 2161 WAKE FOREST NC 27588
Business Address P.O. BOX 2161 WAKE FOREST NC 27588 919-578-5901
Adhera Therapeutics, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-13789 | Film No.: 23787002
SIC: 2834 Pharmaceutical Preparations